In addition, we have identified earlier a specific subgroup of women with luminal B breast malignancies, an ER+ tumor subtype that displays aggressive characteristics including high Ki-67, high tumor grade, poor prognosis, and resistance to endocrine therapy, which exhibit a significant increase in MnSOD-K68-Ac, as compared to luminal A tumors. This evidence concerns the gene SOD2 and neoplasm.